Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Íåâðîëîãèÿ è íåéðîõèðóðãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé íåâðîëîãîâ è íåéðîõèðóðãîâ

Ôîðóì äëÿ îáùåíèÿ âðà÷åé íåâðîëîãîâ è íåéðîõèðóðãîâ Ôîðóì ïðåäíàçíà÷åí äëÿ îáùåíèÿ âðà÷åé ìåæäó ñîáîé.

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 22.01.2007, 17:05
lifecom lifecom âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 22.01.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 6
lifecom *
È âñå òàêè åù¸ ðàç î íîîòðîïàõ

Âñåì èçâåñòíî, ÷òî â ÑØÀ êðèòè÷åñêîå îòíîøåíèå ê íîîòðîïàì â ïðèíöèïå. Íî íåäàâíî îáùàëñÿ ñ êîëëåãîé îòòóäà è îí ðàññêàçàë ìíå, ÷òî ó íèõ äîñòàòî÷íî ïîïóëÿðíû ïðåïàðàòû íà îñíîâå ýêñòðàêòà Ginkgo Biloba EGb 761 (Ìåìîïëàíò, Òàíàêàí, Ãèíêîð. Ýêñòðàêò áûë èçîáðåòåí è ñòàíäàðòèçèðîâàí ïî ðÿäó âåùåñòâ â Ãåðìàíèè. Ñåé÷àñ î÷åíü ìíîãî ïðîèçâîäèòåëåé ýòîãî ëåê. ñðåäñòâà). Íî áîëüøå âñåãî ìåíÿ óäèâèëî, ÷òî ñàìè âðà÷è ÷àñòî ïðèíèìàþò ýòè ïðåïàðàòû äëÿ "óñòîé÷èâîñòè ê ñòðåññó". Ó ìåíÿ åñòü íåáîëüøîé îïûò ïðèìåíåíèÿ ýòîãî ïðåïàðàòà. Êëèíè÷åñêè íàáëþäàåòñÿ äîñòàòî÷íî íåïëîõîé ýôôåêò ó "ðåàáèëèòàöèîííûõ" ïàöèåíòîâ ïîñëå ÒÈÀ, èíñóëüòîâ, ó ïàöèåíòîâ ñ äåìåíöèåé.
Õîòåëîñü áû óçíàòü ìíåíèå êîëëåã.
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 22.01.2007, 17:24
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ïðåïàðàò óâåëè÷èâàåò ðèñê êðîâîòå÷åíèé, îñîáåííî ó ïàöèåíòîâ ïðèíèìàþøèõ îäíîâðåìåííî êóìàäèí èëè àñïèðèí.

Ginkgo Biloba
The active ingredients in Ginkgo biloba extract account for its antioxidant properties and its ability to inhibit platelet aggregation. Consequently, this herbal product is promoted for use in improving cognitive function and blood flow. To date, however, at least four reports of spontaneous bleeding in association with use of Ginkgo biloba.
May increase the possibility of bleeding if taken with Aspirin, warfarin (Coumadin), ticlopidine (Ticlid), clopidogrel (Plavix), dipyridamole (Persantine)
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 22.01.2007, 18:36
Àâàòàð äëÿ riltsov
riltsov riltsov âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 17.01.2005
Ãîðîä: Õàðüêîâ, Óêðàèíà
Ñîîáùåíèé: 4,054
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 649 ðàç(à) çà 631 ñîîáùåíèé
riltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåriltsov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ê ñîæàëåíèþ, êëèíè÷åñêîå âïå÷àòëåíèå îá ýôôåêòèâíîñòè òîãî èëè èíîãî ïðåïàðàòà âåñüìà ñóáúåêòèâíî. Îñîáåííî ýòî êàñàåòñÿ «ðåàáèëèòàöèîííûõ» ïàöèåíòîâ. ß ïðèìåíÿþ ïðåïàðàòû èç ãèíêãî áèëîáû. Íî èëëþçèé ïî ïîâîäó ýòèõ ïðåïàðàòîâ ó ìåíÿ íåò. Äîêàçàòåëüíàÿ áàçà ñëàáàÿ, íî âñå-òàêè ïðèñóòñòâóåò. Ðåçþìå â ýòîì
ïîñòå èç ñòàòüè - [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ].

Íå äóìàþ, ÷òî àìåðèêàíöû èëè åâðîïåéöû íå ëþáÿò íîîòðîïû. Ïðîñòî íåò îñíîâàíèé äëÿ øèðîêîãî èõ ïðèìåíåíèÿ. Äîêàçàíà íåýôôåêòèâíîñòü ïèðàöåòàìà â ëå÷åíèè èíñóëüòà (èññëåäîâàíèå PASS). Íî îòå÷åñòâåííûå íåâðîëîãè ñ çàâèäíûì óïîðñòâîì ïðîäîëæàþò íàçíà÷àòü ïèðàöåòàì âñåì ïàöèåíòàì, ïåðåíåñøèì èíñóëüò. Âèäèìî íàáëþäàþò êëèíè÷åñêèé ýôôåêò. Âñå äåëî â òîì, ÷òî ïîñëå èíñóëüòà âîññòàíîâëåíèå ìîæåò ïðîèñõîäèòü íåçàâèñèìî îò ëå÷åíèÿ. Êàê îòëè÷èòü óëó÷øåíèå îò ïðåïàðàòà, îò óëó÷øåíèÿ êîòîðîå ïðîèñõîäèò â ñèëó ñàìîñòîÿòåëüíîãî ðåãðåññà ñèìïòîìîâ. Äëÿ ýòîãî íóæíû èññëåäîâàíèÿ.

Êîêðàíîâñèé îáçîð:

Ginkgo Biloba for Acute Ischemic Stroke
Stroke 2006;37;574-575; originally published online Jan 5, 2006;
Xianrong Zeng, Ming Liu, Yousong Yang, Yang Li and Kjell Asplund

Implications for Practice

There is no scientific support from high-quality studies for
the routine use of Ginkgo biloba extract in the treatment of
patients with acute ischemic stroke.

Implications for Research

Our meta-analysis suggests that Ginkgo biloba extract intravenous
injections and tablets improve neurological impairment
after acute ischemic stroke. However, a caveat is that
with 1 exception, the trials included were assessed to be of
inferior methodological quality. High-quality, large-scale
randomized trials are needed to confirm or refute the results.
Future trials should overcome the methodological limitations
of the trials presented in this review. In particular, they should
assure true randomization, adequate concealment of allocation,
blinding of outcome assessors, use functional outcome
as the primary outcome measured at long-term follow-up, and
they should be large enough to provide adequate statistical
power.

Êîììåíòàðèè ê ñîîáùåíèþ:
EVP îäîáðèë(à):
yananshs îäîáðèë(à):
Mikhail îäîáðèë(à):
BASS îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 22.01.2007, 19:42
Mikhail Mikhail âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 02.12.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 3,214
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 121 ðàç(à) çà 119 ñîîáùåíèé
Mikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ß òîæå èçðåäêà ïðèìåíÿþ ïðåïàðàòû ãèíêî-áèëîáà ïðè íà÷àëüíûõ êîãíèòèâíûõ íàðóøåíèÿõ. ×åñòíî ñêàçàòü íà ìîé âçãëÿä ýôôåêòèâíîñòü ñîìíèòåëüíà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 22.01.2007, 20:44
Àâàòàð äëÿ Gilarov
Gilarov Gilarov âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 7,196
Ïîáëàãîäàðèëè 713 ðàç(à) çà 691 ñîîáùåíèé
Gilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåGilarov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íó óæ åñëè íà òî ïîøëî, åñòü åùå è âàçîáðàë, ñîäåðæàùèé äèãèäðîýðãîêðèïòèí. Ïî íåìó òîæå êîå-êàêàÿ áàçà åñòü, õîòÿ è ñîìíèòåëüíàÿ...
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 22.01.2007, 21:17
Mikhail Mikhail âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 02.12.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 3,214
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 121 ðàç(à) çà 119 ñîîáùåíèé
Mikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Gilarov
Íó óæ åñëè íà òî ïîøëî, åñòü åùå è âàçîáðàë, ñîäåðæàùèé äèãèäðîýðãîêðèïòèí. Ïî íåìó òîæå êîå-êàêàÿ áàçà åñòü, õîòÿ è ñîìíèòåëüíàÿ...
Íó îí âðîäå êàê íå ñîâñåì íîîòðîï...
Õîòÿ ñàìî ïîíÿòèå íîîòðîïîâ äîâîëüíî ðàñïëûâ÷àòî.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 23.01.2007, 08:52
Àâàòàð äëÿ MKMED
MKMED MKMED âíå ôîðóìà ÂÐÀ×
Êàíäèäàò â âåòåðàíû ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.05.2006
Ãîðîä: Óôà
Ñîîáùåíèé: 1,530
Ïîáëàãîäàðèëè 467 ðàç(à) çà 458 ñîîáùåíèé
MKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMKMED ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íå çàìåòèë ïîïóëÿðíîñòè Ãèíêî Áèëîáà ïðè îáùåíèè ñ çàîêåàíñêèìè êîëëåãàìè.
Ïðàâäà ó íèõ íåêîòîðûå ëþäò óïîòðåáëÿþò Ãèíêî êàê ïðîñòî äîáàâêà ê ÷àþ (òèïà ðîìàøêè ó íàñ).

Íà ñêîëüêî ÿ çíàþ, â èíñóëüòíîé êëèíèêå íèêàêèõ íåéðîïðîòåêòîðîâ è íîîòðîïîâ íå èñïîëüçóþò (òå êîãî ÿ çíàþ).

À àëêîëîèäû ñïîðûíüè ñêîðåå äåéñòâóþò íà àäðåíåðãè÷åñêóþ ñèñòåìó ñîñóäîâ, ÷åì íà íåéðîíû (÷òîá áûòü íåéðîïðîòåêòîðàìè)

Êîììåíòàðèè ê ñîîáùåíèþ:
Mikhail îäîáðèë(à): íåóæåëè â Óôå íå íàçíà÷àþò öåðåáðîëèçèí èíñóëüòíèêàì?
Baul îäîáðèë(à): Îõîòíî âåðþ ïðî öåðåðîëèçèí, ó÷èòûâàÿ ÷òî EBM ðåêîìåíäàöèè ïî èíñóëüòó ðàçðàáàòûâàþò â Óôå
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 23.01.2007, 12:56
lifecom lifecom âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 22.01.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 6
lifecom *
Öèòàòà:
Ñîîáùåíèå îò yananshs
ïðåïàðàò óâåëè÷èâàåò ðèñê êðîâîòå÷åíèé, îñîáåííî ó ïàöèåíòîâ ïðèíèìàþøèõ îäíîâðåìåííî êóìàäèí èëè àñïèðèí.
Specific clinical trials to address this question have shown that EGb 761 does not influence blood coagulation. This is further supported by an evaluation of a large prescription data base showing that the relative risk of bleeding in patient populations is totally independent of whether the patients are taking EGb 761® or not.

(Koch: Phytomedicine 2005; Markowitz: J Clin Psychopharmacol 2003; Greenblatt: J Clin Pharmacol 2006; Mohutsky: Am J Ther 2006; Engelsen: Thromb Haemost 2002; Bal dit Sollier: Clin Lab Haem 2003; Köhler: Blood Coagul Fibrinolysis 2004; Jiang: Br J Clin Pharmacol 2005; Halil: Blood Coagul Fibrinolysis 2005 Ernst: Perfusion 2005; Gaus: Methods Inf Med 2005; 44: 697-703)
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 23.01.2007, 13:05
lifecom lifecom âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 22.01.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 6
lifecom *
Öèòàòà:
Ñîîáùåíèå îò MKMED
Íà ñêîëüêî ÿ çíàþ, â èíñóëüòíîé êëèíèêå íèêàêèõ íåéðîïðîòåêòîðîâ è íîîòðîïîâ íå èñïîëüçóþò.
ß íå ãîâîðþ îá èíñóëüòå, ÿ ãîâîðþ î ðåàáèëèòàöèè, î êîãíèòèâå. Íî, íà ìîé âçãëÿä, äàæå ïðè èíñóëüòå íåîáõîäèìû íåéðîïðîòåêòîðû. Âîïðîñ â òîì - êàêèå? Âåäü ó ðÿäà èç íèõ åñòü ìàññà íåäîñòàòêîâ è ïîáî÷íûõ äåéñòâèé. EGb 761 - áåçîïàñíîå ñðåäñòâî è, ñêîðåå âñåãî, ýòî ïðèâëåêàåò íàøèõ çàîêåàíñêèõ êîëëåã.

Öèòàòà:
Ñîîáùåíèå îò MKMED
À àëêîëîèäû ñïîðûíüè ñêîðåå äåéñòâóþò íà àäðåíåðãè÷åñêóþ ñèñòåìó ñîñóäîâ, ÷åì íà íåéðîíû (÷òîá áûòü íåéðîïðîòåêòîðàìè)
Íå ïîíèìàþ, ïðè÷åì çäåñü àëêàëîèäû ñïîðûíüè?
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 23.01.2007, 14:00
Àâàòàð äëÿ rizhova
rizhova rizhova âíå ôîðóìà ÂÐÀ×
Çàñëóæåííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 03.03.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 817
Ïîáëàãîäàðèëè 87 ðàç(à) çà 86 ñîîáùåíèé
rizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìårizhova ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò lifecom

Íå ïîíèìàþ, ïðè÷åì çäåñü àëêàëîèäû ñïîðûíüè?
Ñîîáùåíèå âûøå:
Öèòàòà:
Ñîîáùåíèå îò Gilarov
Íó óæ åñëè íà òî ïîøëî, åñòü åùå è âàçîáðàë, ñîäåðæàùèé äèãèäðîýðãîêðèïòèí. Ïî íåìó òîæå êîå-êàêàÿ áàçà åñòü, õîòÿ è ñîìíèòåëüíàÿ...
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 23.01.2007, 16:01
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êàê çàîêåàíñêèé êîëëåãà ìîãó ñêàçàòü, ÷òî Ãèíêî ïîïóëÿðåí ñðåäè ðóññêèõ áàáóøåê. Íî îíè ýòî ñåáå ñàìè íàçíà÷àþò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 23.01.2007, 16:05
Mikhail Mikhail âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 02.12.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 3,214
Ñêàçàë(à) ñïàñèáî: 3
Ïîáëàãîäàðèëè 121 ðàç(à) çà 119 ñîîáùåíèé
Mikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMikhail ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò lifecom
ß íå ãîâîðþ îá èíñóëüòå, ÿ ãîâîðþ î ðåàáèëèòàöèè, î êîãíèòèâå. Íî, íà ìîé âçãëÿä, äàæå ïðè èíñóëüòå íåîáõîäèìû íåéðîïðîòåêòîðû. Âîïðîñ â òîì - êàêèå?

Íèêòî íå ñïîðèò, ÷òî îíè íåîáõîäèìû. È âåñü ìèð áúåòñÿ íàä èõ ïîèñêîì. Íî ýòî æå íå ïîâîä èñïîëüçîâàòü "íåéðîïðîòåêòîðû", êîòîðûå íè÷åãî íå çàùèùàþò. (ÿ èìåþ ââèäó øèðîêóþ ïðàêòèêó îòå÷åñòâåííîé íåâðîëîãèè)
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 23.01.2007, 16:30
lifecom lifecom âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 22.01.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 6
lifecom *
Öèòàòà:
Ñîîáùåíèå îò Mikhail
Íèêòî íå ñïîðèò, ÷òî îíè íåîáõîäèìû. È âåñü ìèð áúåòñÿ íàä èõ ïîèñêîì. Íî ýòî æå íå ïîâîä èñïîëüçîâàòü "íåéðîïðîòåêòîðû", êîòîðûå íè÷åãî íå çàùèùàþò. (ÿ èìåþ ââèäó øèðîêóþ ïðàêòèêó îòå÷åñòâåííîé íåâðîëîãèè)
Âû õîòèòå ñêàçàòü ÷òî ñåé÷àñ íåò äîñòîéíûõ "íåéðîïðîòåêòîðîâ" â ïîëíîì ïîíèìàíèè ýòîãî òåðìèíà? Äàâàéòå, ìîæåò áûòü, ñôîðìóëèðóåì, ÷òî èìåííî ìû õîòèì îò "íåéðîïðîòåêòîðà", ÷òî "íå õîòèì", à ïîòîì ïîïûòàåìñÿ îöåíèòü, ñóùåñòâóþò òàêèå ïðåïàðàòû èëè íåò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 23.01.2007, 16:36
lifecom lifecom âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 22.01.2007
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 6
lifecom *
Öèòàòà:
Ñîîáùåíèå îò yananshs
Êàê çàîêåàíñêèé êîëëåãà ìîãó ñêàçàòü, ÷òî Ãèíêî ïîïóëÿðåí ñðåäè ðóññêèõ áàáóøåê. Íî îíè ýòî ñåáå ñàìè íàçíà÷àþò.
Èíòåðåñíî, ïî÷åìó èìåííî ñðåäè ðóññêèõ? Âû èìååòå ââèäó, ÷òî âûõîäöû èç Ðîññèè "ñèëüíåå" ðàçáèðàþòñÿ â íîîòðîïíîé òåðàïèè èëè èìåþò áîëåå âûñîêèé èíòåëëåêòóàëüíûé óðîâåíü, äîñòàòî÷íûé ïîíÿòü, ÷òî èì íåîáõîäèìà òåðàïèÿ EGb 761? È âîîáùå, íà "ðóññêèõ áàáóøåê" òàì ðàâíÿþòñÿ èëè íàîáîðîò?
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 23.01.2007, 17:00
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íà Áðàéòîí Áè÷ åñòü íåêàÿ êîíòîðà "Forces of Nature". Ïðîäàåò è àêòèâíî ðåêëàìèðóåò ÁÀÄ. Åñëè ïîñëóøàòü ðóññêîå ðàäèî, òî ñòàíîâèòñÿ ÿñíî, ÷òî òîëüêî â ýòîé êîíòîðå ìîæíî íàéòè ñàìûå ýôôåêòèâíûå, óíèêàëüíûå, íå èìåþøèå àíàëîãîâ ñðåäñòâà îò âñåõ áîëåçíåé. È âñå áåç ðåöåïòà. è ê âðà÷ó õîäèòü íå íàäî. "Íàøè âûñîêîïðîôåññèîíàëüíûå ñîòðóäíèêè ïîìîãóò âàì ïîäîáðàòü èíäèâèäóàëüíûé êîìïëåêñ". Âîò è Ãèíêî òàì òîæå ðåêëàìèðóåòñÿ. Áàáóøêè ñëóøàþò ðàäèî è ïîêóïàþò è ïîäðóæêàì ñîâåòóþò.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 19:22.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.